Get Guardian on GoogleDr. Osagwu Nnenna Anestina, CEO and Managing Director of InnovateMed Research & Clinical Solution, is playing a key role in advancing drug regulation and mental healthcare reform in Nigeria.
Through a combination of research, consultancy, and policy advocacy, Dr. Osagwu has become a notable figure in public health development across the country.
Under her leadership, InnovateMed has consulted for several major pharmaceutical firms and government agencies, contributing to the review and strengthening of national regulatory frameworks. These efforts have led to notable improvements in drug distribution systems, with a focus on enhancing transparency, efficiency, and access to safe medication for the Nigerian public.
Dr. Osagwu’s collaboration with the National Agency for Food and Drug Administration and Control (NAFDAC), through the Nigerian Society of Clinical Pharmacology and Therapeutics (NSCPT), has supported ongoing efforts to reduce delays in drug approval processes and tighten manufacturing standards. Stakeholders say these reforms are helping position Nigeria as a hub for pharmaceutical research and development in Africa.
In addition to her work in pharmacology, Dr. Osagwu has also contributed to mental health policy discourse. At the 15th Biennial International Conference on Drugs, Alcohol and Society in Africa (CRISA 2024), she served as a virtual panellist during a session titled “Improving Access to Treatment for Substance Use Disorders: Emerging Strategies and Persistent Challenges.”
Drawing on her research and field experience, she presented practical approaches to improving treatment accessibility for substance use disorders across the continent.
Conference organisers report that her recommendations have gained traction among policymakers and international development partners, with further discussions expected to influence national strategies on mental health in the coming months.
Observers note that Dr. Osagwu’s growing influence in healthcare policy and clinical research highlights a broader shift towards evidence-based reform in Nigeria’s health sector.
With continued engagement at the national and regional levels, she is expected to play an ongoing role in shaping health outcomes and regulatory standards across West Africa.
